The review synthesizes evidence on whether Alzheimer’s disease medications can improve neurocognitive outcomes in children ...

Surprising findings published in PNAS have implications for understanding and treating neurological and neuropsychiatric disorders.

Drugs that act on NMDA (N-methyl-D-aspartate) receptors, which are essential for learning, memory and moment-by-moment consciousness, are key for treating neuropsychiatric disorders. These drugs were ...

The shadow of Alzheimer's disease looms large over our aging population. It is more than a memory disorder; it's a ...